$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Oct 16, 2025)
$5.23B
Market Cap
173.44
P/E Ratio
0.09
EPS
$30.36
52 Week High
$8.93
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Telix Pharmaceuticals Limited is an innovative commercial-stage biopharmaceutical company dedicated to advancing the field of radiopharmaceuticals for the diagnosis and treatment of cancer and rare diseases. With its headquarters in North Melbourne, Australia, Telix operates in key markets including the United States, Belgium, Japan, and Switzerland, leveraging its expertise to deliver cutting-edge therapeutic and diagnostic solutions. The company's strategic focus on unmet medical needs underscores its commitment to improving patient outcomes through targeted therapies, positioning it as a promising player in the evolving biopharmaceutical landscape.